These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25001657)

  • 1. Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid treatment in mice.
    Bellavia M; Rappa F; Lo Bello M; Brecchia G; Tomasello G; Leone A; Spatola G; Uzzo ML; Bonaventura G; David S; Damiani P; Hajj Hussein I; Zeenny MN; Jurjus A; Schembri-Wismayer P; Cocchi M; Zummo G; Farina F; Gerbino A; Cappello F; Traina G
    J Biol Regul Homeost Agents; 2014; 28(2):251-61. PubMed ID: 25001657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model.
    Traina G; Menchetti L; Rappa F; Casagrande-Proietti P; Barbato O; Leonardi L; Carini F; Piro F; Brecchia G
    J Biol Regul Homeost Agents; 2016; 30(3):895-901. PubMed ID: 27655518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis.
    Peran L; Camuesco D; Comalada M; Bailon E; Henriksson A; Xaus J; Zarzuelo A; Galvez J
    J Appl Microbiol; 2007 Oct; 103(4):836-44. PubMed ID: 17897185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.
    Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E
    Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifidobacterium longum and VSL#3
    Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X
    Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.
    Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B
    Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.
    Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C
    Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.
    del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG
    J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications.
    Hörmannsperger G; Clavel T; Hoffmann M; Reiff C; Kelly D; Loh G; Blaut M; Hölzlwimmer G; Haller D
    J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S10-5. PubMed ID: 20562631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Probiotic therapy using live combined bifidobacterium, lactobacillus and enterococcus for experimental colitis in rats model].
    Wan YM; Zhu YQ; Xia B; Luo J
    Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):418-21. PubMed ID: 20646418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
    Konturek PC; Konturek K; Brzozowski T; Wojcik D; Magierowski M; Targosz A; Krzysiek-Maczka G; Sliwowski Z; Strzalka M; Magierowska K; Szczyrk U; Kwiecien S; Ptak-Belowska A; Neurath M; Dieterich W; Wirtz S; Zopf Y
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
    Xu J; Zheng C; Huang Y; Liang Y
    Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice.
    Zhao HM; Huang XY; Zuo ZQ; Pan QH; Ao MY; Zhou F; Liu HN; Liu ZY; Liu DY
    World J Gastroenterol; 2013 Feb; 19(5):742-9. PubMed ID: 23430765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of intestinal lymphocyte homing by means of pinhole SPECT in a TNBS colitis mouse model.
    Bennink RJ; van Montfrans C; de Jonge WJ; de Bruin K; van Deventer SJ; te Velde AA
    Nucl Med Biol; 2004 Jan; 31(1):93-101. PubMed ID: 14741574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partially hydrolysed guar gum ameliorates murine intestinal inflammation in association with modulating luminal microbiota and SCFA.
    Takagi T; Naito Y; Higashimura Y; Ushiroda C; Mizushima K; Ohashi Y; Yasukawa Z; Ozeki M; Tokunaga M; Okubo T; Katada K; Kamada K; Uchiyama K; Handa O; Itoh Y; Yoshikawa T
    Br J Nutr; 2016 Oct; 116(7):1199-1205. PubMed ID: 27604176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria.
    Pavan S; Desreumaux P; Mercenier A
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):696-701. PubMed ID: 12853407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response.
    Thakur BK; Saha P; Banik G; Saha DR; Grover S; Batish VK; Das S
    Int Immunopharmacol; 2016 Jul; 36():39-50. PubMed ID: 27107798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragaloside IV ameliorates 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis implicating regulation of energy metabolism.
    Jiang XG; Sun K; Liu YY; Yan L; Wang MX; Fan JY; Mu HN; Li C; Chen YY; Wang CS; Han JY
    Sci Rep; 2017 Feb; 7():41832. PubMed ID: 28150820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid.
    Llopis M; Antolín M; Guarner F; Salas A; Malagelada JR
    Gut; 2005 Jul; 54(7):955-9. PubMed ID: 15951541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of probiotics on toll-like receptor 4 expression in an experimental model of ulcerative colitis.
    Yang X; Fu Y; Liu J; Ren HY
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):661-665. PubMed ID: 24142717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.